Instruction for use: Beclometasone-aeronativ
I want this, give me price
ATX Code R03BA01 Beclometasone
Active substance: Beclometasone
Pharmacological group
Glucocorticosteroid for topical use [Glucocorticosteroids]
Nosological classification (ICD-10)
J44 Other chronic obstructive pulmonary disease
Allergic bronchitis, Bronchitis asthma, Asthmatic bronchitis, wheeze bronchitis, Bronchitis is an obstructive, bronchi disease, Shortness of sputum in acute and chronic respiratory diseases, Cough in inflammatory diseases of the lung and bronchus, Reversible airflow obstruction, Reversible obstructive airway disease, Obstructive bronchitis disease, Obstructive lung disease, Obstructive bronchitis, Spastic bronchitis, Chronic lung disease, Chronic nonspecific lung diseases, Chronic obstructive pulmonary disease, Chronic obstructive bronchitis, Chronic obstructive airway disease, Chronic obstructive pulmonary disease, Restrictive lung pathology
J44.9 Chronic obstructive pulmonary disease, unspecified
Obstructive pulmonary diseases, Bronchial obstruction, bronchial obstruction, Exacerbation of chronic obstructive pulmonary disease, reversible airflow obstruction, Reversible airway obstruction, panbronchiolitis, Panbronhit, COPD, Chronic pulmonary infection, Chronic infection of the lower respiratory tract, Chronic obstructive pulmonary disease, Chronic obstructive pneumonia, Chronic lung disease, Chronic obstructive pulmonary disease, Chronic bronchopulmonary disease, Chronic broncho-pulmonary diseases, Airway obstruction
J45 Asthma
Asthma physical effort, status asthmaticus, Bronchial asthma, Asthma lung flow, Bronchial asthma with obstruction of sputum discharge, Bronchial asthma heavy currents, Bronchial asthma physical effort, hypersecretory asthma, Hormone-dependent form of bronchial asthma, Relief of asthma attacks in bronchial asthma, Non-allergic asthma, nocturnal asthma, Exacerbation of asthma, Asthma attacks, Endogenous forms of asthma, Night asthma, Cough with bronchial asthma
Composition
Aerosol for inhalation dosage 1 dose
active substance:
Beclometasone dipropionate 50/100/250 μg
Auxiliary substances: absolute ethyl alcohol of grade A - 10/10/10 mg; Triethyl citrate - 0.011 / 0.011 / 0.011 mg; Propellant R 134a (1,1,1,2-tetrafluoroethane) 60.45 / 60.45 / 60.45 mg
pharmachologic effect
Pharmacological action - anti-asthmatic, glucocorticoid.
Dosing and Administration
Inhalation.
Bronchial asthma
Adults and children aged 12 years and over. Beclometasone aeronativ are used regularly (even in the absence of symptoms of the disease), the dose of Beclometasone dipropionate is selected taking into account the severity of bronchial asthma and the clinical effect in each specific case. The daily dose is divided into several doses.
Recommended initial doses of the drug:
- bronchial asthma of light course - 200-600 mcg / day;
- bronchial asthma of moderate course - 600-1000 mcg / day;
- a bronchial asthma of a heavy current - 1000-2000 mkg / sut.
Children aged 4 to 12 years. Up to 400 mcg / day in several doses.
Depending on the individual response of the patient, the dose of the drug can be increased until the appearance of a clinical effect or reduced to the minimum effective dose.
When switching to a high dose of inhaled Beclometasone dipropionate in many patients receiving systemic GCS (glucocorticosteroids), it is possible to reduce their dose or cancel them altogether.
COPD (chronic obstructive pulmonary disease)
The maximum recommended dose of Beclometasone aeronaut with COPD is 2000 μg / day.
If you miss an inhalation accidentally, the next dose should be taken at the appropriate time in accordance with the treatment regimen.
The introduction can be carried out using special dispensers (spacers) that improve the distribution of the drug in the lungs and reduce the risk of side effects.
Special patient groups
Patients with impaired liver function. In patients with impaired liver function, a dose reduction is not required.
Patients with impaired renal function. In patients with impaired renal function, a dose reduction is not required.
Instructions for inhalation
Beclometasone aeronativ are intended for inhalation use only.
Before using the inhaler for the first time, or if the inhaler has not been used for a week or longer, it should be checked. To do this, remove the protective cap from the mouthpiece of the inhaler, shake the inhaler well and press the balloon, releasing one jet of the drug into the air.
Conduction of inhalation
Step 1. Remove the protective cap from the inhaler mouthpiece
Step 2. Vigorously shake the inhaler.
Step 3. Make a slow, full exhalation.
Step 4. Hold the balloon as shown in Figure 2, tightly grasp the mouthpiece. The cylinder must be pointed upside down.
Step 5. Take as deep as possible inhalation, simultaneously quickly press the bottom of the cylinder until one inhalation dose is released.
Step 6. Hold your breath for a few seconds, then take the mouthpiece out of your mouth and exhale slowly.
Step 7. Put the protective cap on the mouthpiece of the inhaler.
Repeat steps 3-6 to obtain a second inhalation dose, if necessary.
After inhalation, it is recommended to rinse the mouth and throat with water. Do not swallow water.
Cleaning the inhaler
Regularly (once a week), the mouthpiece of the inhaler should be cleaned
Remove the metal can from the plastic case and rinse the case and cap with warm water. Do not use hot water. Thoroughly dry, but do not use heating devices for this. Place the can in the case and put on the cap. Do not immerse the metal can into the water.
Form of issue
Aerosol for inhalation dosed, 50 mcg / dose, 100 mcg / dose, 250 mcg / dose. For 200 doses of the drug in an aluminum bottle with a spray dosing nozzle. Each cylinder, together with the instruction for use, is placed in a pack of cardboard box.
Terms of leave from pharmacies
On prescription.
Storage conditions
In the dark place at a temperature of no higher than 25 ° C (do not freeze). Away from heating appliances.
Keep out of the reach of children.
Shelf life
2 years.
Do not use after the expiry date printed on the package.